…
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
TruScreen Group Limited develops and commercialises a non‑invasive cervical screening device intended to detect precancerous and cancerous tissue at point of care. The company may benefit from rising demand for cervical screening, expansion in emerging markets and recurring revenue from consumables, which could support longer‑term commercialisation and scale and may make it attractive to investors seeking exposure to medical diagnostics.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
Sector: Health Care Industry: Health Care Equipment & Supplies
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.